Suturing vs Biological Adhesive in Simple Lacerations of Hand (sutvsglu)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00524888
Recruitment Status : Unknown
Verified August 2007 by Hadassah Medical Organization.
Recruitment status was:  Not yet recruiting
First Posted : September 5, 2007
Last Update Posted : September 5, 2007
Information provided by:
Hadassah Medical Organization

September 4, 2007
September 5, 2007
September 5, 2007
September 2007
Not Provided
Wound appearance [ Time Frame: 3 Months ]
Same as current
No Changes Posted
pain of treatment and time length of treatment [ Time Frame: 3 months ]
Same as current
Not Provided
Not Provided
Suturing vs Biological Adhesive in Simple Lacerations of Hand
Suturing Vs Adhesion for Hand Lacerations in the ER A Randomized Prospective Study
To assess the difference in clinical outcome between lacerations in the hand treated by sutures versus treated by tissue adhesive.
Not Provided
Not Applicable
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Primary Purpose: Treatment
  • Procedure: suturing laceration
    suturing simple lacerations of the hand
  • Procedure: bioadhesive
    using bioadhesive on simple lacerations of the hand
  • Active Comparator: 1
    suturing lacerations of the hand
    Intervention: Procedure: suturing laceration
  • Active Comparator: 2
    using bioadhesive on lacerations of hand
    Intervention: Procedure: bioadhesive
Not Provided

*   Includes publications given by the data provider as well as publications identified by Identifier (NCT Number) in Medline.
Unknown status
Same as current
Not Provided
Not Provided

Inclusion Criteria:

  • Any age
  • Hand laceration distal to the volar wrist crease.

Exclusion Criteria:

  • Fracture , tendon, artery involvement, more than 8 hours from laceration to trx,
  • Immunosuppression
  • Anticoagulation therapy
  • Diabetes
  • Unable to achieve homeostasis in more than 15 minutes
  • Unwilling to participate in the study
  • Unable to participate in the follow up or bite of any kind.
Sexes Eligible for Study: All
Child, Adult, Senior
Contact information is only displayed when the study is recruiting subjects
Not Provided
Not Provided
Not Provided
Not Provided
Hadassah Medical Organization
Not Provided
Principal Investigator: Michael Icekson, MD Hadassah Medical Organization
Hadassah Medical Organization
August 2007

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP